Titlebook: Nuclear Medicine Therapy; Principles and Clini Cumali Aktolun,Stanley J. Goldsmith Book 2013 Springer Science+Business Media New York 2013

Microaneurysm

Antagonist

Radioimmunotherapy of Lymphomatries, it is the most common hematologic malignancy. At the present time, lymphomas, both Hodgkin’s and non-Hodgkin’s, represent 5–6 % of all malignant tumors (excluding superficial skin cancers) in these countries. In 2008, there were approximately 450,000 men and women living in the United States

相容

性別

Radiophosphorus Treatment of Myeloproliferative Neoplasmss been used in numerous clinical settings, virtually all now obsolete except for a few remaining important indications in the treatment of myeloproliferative neoplasia. This chapter will review the history of radiophosphorus in medicine, the dosimetry of .P-phosphate, and important clinical applicat

評論者

DEFER

逃避責任

同位素

contradict

Radioiodine Therapy of Differentiated Thyroid Cancers (carcinomas of thyrocytes and C-cells), and from non-epithelial cells (lymphomas and sarcomas). Thyrocytes are the main functional cells that produce thyroid hormones (T3 and T4), which are vital for human metabolism. The epithelial tumors can be divided into the well-differentiated (papillary and

adulterant